Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Vaccines

  Free Subscription


Articles published in Arch Virol

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    May 2019
  1. ZHANG L, Liu X, Zhang Q, Zhou P, et al
    Biological characterization and pathogenicity of a newly isolated Chinese highly virulent genotype GIIa porcine epidemic diarrhea virus strain.
    Arch Virol. 2019;164:1287-1295.
    PubMed     Text format     Abstract available


    April 2019
  2. YANG R, Wang L, Sheng J, Huang Q, et al
    Combinatory effects of vaccinia virus VG9 and the STAT3 inhibitor Stattic on cancer therapy.
    Arch Virol. 2019 Apr 24. pii: 10.1007/s00705-019-04257.
    PubMed     Text format     Abstract available


  3. KONONOV A, Byadovskaya O, Kononova S, Yashin R, et al
    Detection of vaccine-like strains of lumpy skin disease virus in outbreaks in Russia in 2017.
    Arch Virol. 2019 Apr 4. pii: 10.1007/s00705-019-04229.
    PubMed     Text format     Abstract available


    March 2019
  4. ZHAO Y, Chang J, Zhang B, Tong P, et al
    TLR-5 agonist Salmonella abortus equi flagellin FliC enhances FliC-gD-based DNA vaccination against equine herpesvirus 1 infection.
    Arch Virol. 2019 Mar 19. pii: 10.1007/s00705-019-04201.
    PubMed     Text format     Abstract available


  5. KAMEL M, El-Sayed A, Castaneda Vazquez H
    Foot-and-mouth disease vaccines: recent updates and future perspectives.
    Arch Virol. 2019 Mar 19. pii: 10.1007/s00705-019-04216.
    PubMed     Text format     Abstract available


    February 2019
  6. NURPEISOVA A, Kassenov M, Rametov N, Tabynov K, et al
    Analysis of the efficacy of an adjuvant-based inactivated pandemic H5N1 influenza virus vaccine.
    Arch Virol. 2019 Feb 10. pii: 10.1007/s00705-019-04147.
    PubMed     Text format     Abstract available


  7. FAKHRI O, Hartley CA, Devlin JM, Browning GF, et al
    Development and application of high-resolution melting analysis for the classification of infectious laryngotracheitis virus strains and detection of recombinant progeny.
    Arch Virol. 2019;164:427-438.
    PubMed     Text format     Abstract available


    January 2019
  8. HU J, Liang Y, Hu Z, Wang X, et al
    Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens.
    Arch Virol. 2019 Jan 22. pii: 10.1007/s00705-018-04142.
    PubMed     Text format     Abstract available


  9. MULLER C, Ulrich R, Franzke K, Muller M, et al
    Crude extracts of recombinant baculovirus expressing rabbit hemorrhagic disease virus 2 VLPs from both insect and rabbit cells protect rabbits from rabbit hemorrhagic disease caused by RHDV2.
    Arch Virol. 2019;164:137-148.
    PubMed     Text format     Abstract available


    October 2018
  10. MURGIA MV, Mogler M, Certoma A, Green D, et al
    Evaluation of an African swine fever (ASF) vaccine strategy incorporating priming with an alphavirus-expressed antigen followed by boosting with attenuated ASF virus.
    Arch Virol. 2018 Oct 26. pii: 10.1007/s00705-018-4071.
    PubMed     Text format     Abstract available


  11. LEE MS, Jang EY, Cho J, Kim K, et al
    Development and comparison of two H5N8 influenza A vaccine candidate strains.
    Arch Virol. 2018 Oct 5. pii: 10.1007/s00705-018-4062.
    PubMed     Text format     Abstract available


  12. KUWATA R, Shimoda H, Phichitraslip T, Prasertsincharoen N, et al
    Getah virus epizootic among wild boars in Japan around 2012.
    Arch Virol. 2018;163:2817-2821.
    PubMed     Text format     Abstract available


    September 2018
  13. EVSEENKO VA, Kolosova NP, Gudymo AS, Maltsev SV, et al
    Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract.
    Arch Virol. 2018 Sep 17. pii: 10.1007/s00705-018-4023.
    PubMed     Text format     Abstract available


  14. LIU J, Xue L, Hu S, Cheng H, et al
    Chimeric Newcastle disease virus-vectored vaccine protects chickens against H9N2 avian influenza virus in the presence of pre-existing NDV immunity.
    Arch Virol. 2018 Sep 5. pii: 10.1007/s00705-018-4016.
    PubMed     Text format     Abstract available


    August 2018
  15. PATHINAYAKE PS, Gayan Chathuranga WA, Lee HC, Chowdhury MYE, et al
    Inactivated enterovirus 71 with poly-gamma-glutamic acid/Chitosan nano particles (PC NPs) induces high cellular and humoral immune responses in BALB/c mice.
    Arch Virol. 2018;163:2073-2083.
    PubMed     Text format     Abstract available


    July 2018
  16. VAN REGENMORTEL MHV
    Viral species, viral genomes and HIV vaccine design: is the rational design of biological complexity a utopia?
    Arch Virol. 2018 Jul 26. pii: 10.1007/s00705-018-3955.
    PubMed     Text format     Abstract available


  17. ANDRIEU JM, Lu W
    A 30-year journey of trial and error towards a tolerogenic AIDS vaccine.
    Arch Virol. 2018 Jul 24. pii: 10.1007/s00705-018-3936.
    PubMed     Text format     Abstract available


  18. MAEGAWA K, Shibata T, Yamaguchi R, Hiroike K, et al
    Overexpression of a virus-like particle influenza vaccine in Eri silkworm pupae, using Autographa californica nuclear polyhedrosis virus and host-range expansion.
    Arch Virol. 2018 Jul 19. pii: 10.1007/s00705-018-3941.
    PubMed     Text format     Abstract available


  19. EL-DABAE WH, Hussein HA, Rohaim MA, El-Safty MM, et al
    Saponin-adjuvanted vaccine protects chickens against velogenic Newcastle disease virus.
    Arch Virol. 2018 Jul 2. pii: 10.1007/s00705-018-3917.
    PubMed     Text format     Abstract available


  20. SANTOS MR, Assao VS, Santos FAA, Salgado RL, et al
    Utilization of phage display to identify antigenic regions in the PCV2 capsid protein for the evaluation of serological responses in mice and pigs.
    Arch Virol. 2018;163:1877-1887.
    PubMed     Text format     Abstract available


  21. WANG X, Dong K, Long M, Lin F, et al
    Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
    Arch Virol. 2018;163:1851-1861.
    PubMed     Text format     Abstract available


  22. KITAB B, Kohara M, Tsukiyama-Kohara K
    Experimental in vitro and in vivo systems for studying the innate immune response during dengue virus infections.
    Arch Virol. 2018;163:1717-1726.
    PubMed     Text format     Abstract available


    June 2018
  23. EL NAGGAR RF, Rohaim MA, Bazid AH, Ahmed KA, et al
    Biological characterization of wild-bird-origin avian avulavirus 1 and efficacy of currently applied vaccines against potential infection in commercial poultry.
    Arch Virol. 2018 Jun 19. pii: 10.1007/s00705-018-3916.
    PubMed     Text format     Abstract available


    May 2018
  24. LIN W, Lu P, Li A, Wu Y, et al
    Assessing the efficacy of a live vaccine against avian encephalomyelitis virus.
    Arch Virol. 2018 May 16. pii: 10.1007/s00705-018-3862.
    PubMed     Text format     Abstract available


  25. SULCZEWSKI FB, Liszbinski RB, Romao PRT, Rodrigues Junior LC, et al
    Nanoparticle vaccines against viral infections.
    Arch Virol. 2018 May 4. pii: 10.1007/s00705-018-3856.
    PubMed     Text format     Abstract available


    April 2018
  26. LIU C, Liu Y, Chen H, Feng H, et al
    Genetic and immunogenicity analysis of porcine circovirus type 2 strains isolated in central China.
    Arch Virol. 2018;163:937-946.
    PubMed     Text format     Abstract available


    February 2018
  27. MOZHGANI SH, Malekpour SA, Norouzi M, Ramezani F, et al
    Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran.
    Arch Virol. 2018 Feb 13. pii: 10.1007/s00705-018-3764.
    PubMed     Text format     Abstract available


    January 2018
  28. KUMAR B, Asha K, Khanna M, Ronsard L, et al
    The emerging influenza virus threat: status and new prospects for its therapy and control.
    Arch Virol. 2018 Jan 10. pii: 10.1007/s00705-018-3708.
    PubMed     Text format     Abstract available


    December 2017
  29. KHODAMORADI S, Shenagari M, Kheiri MT, Sabahi F, et al
    IRES-based co-expression of influenza virus conserved genes can promote synergistic antiviral effects both in vitro and in vivo.
    Arch Virol. 2017 Dec 21. pii: 10.1007/s00705-017-3682.
    PubMed     Text format     Abstract available


  30. YUAN X, Lin H, Li B, He K, et al
    Efficacy and immunogenicity of recombinant swinepox virus expressing the truncated S protein of a novel isolate of porcine epidemic diarrhea virus.
    Arch Virol. 2017;162:3779-3789.
    PubMed     Text format     Abstract available


  31. ZAIDI SSZ, Hameed A, Ali N, Umair M, et al
    A measles outbreak in Sindh, Pakistan caused by a genotype B3 virus.
    Arch Virol. 2017;162:3603-3610.
    PubMed     Text format     Abstract available


    November 2017
  32. BAGHBAN RAHIMI S, Mohebbi A, Vakilzadeh G, Biglari P, et al
    Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
    Arch Virol. 2017 Nov 17. doi: 10.1007/s00705-017-3647.
    PubMed     Text format     Abstract available


    October 2017
  33. KRISHNAVAJHALA HR, Williams J, Heidner H
    An influenza A virus vaccine based on an M2e-modified alphavirus.
    Arch Virol. 2017 Oct 27. doi: 10.1007/s00705-017-3578.
    PubMed     Text format     Abstract available


    September 2017
  34. TURMAGAMBETOVA AS, Alexyuk PG, Bogoyavlenskiy AP, Zaitseva IA, et al
    Adjuvant activity of saponins from Kazakhstani plants on the immune responses to subunit influenza vaccine.
    Arch Virol. 2017 Sep 21. doi: 10.1007/s00705-017-3560.
    PubMed     Text format     Abstract available


    July 2017
  35. WANG H, Guo S, Li Z, Xu X, et al
    Suspension culture process for H9N2 avian influenza virus (strain Re-2).
    Arch Virol. 2017 Jul 7. doi: 10.1007/s00705-017-3460.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: